Literature DB >> 17196572

Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newborns.

Paola Concolino1, Ettore Capoluongo, Concetta Santonocito, Giovanni Vento, Milena Tana, Costantino Romagnoli, Cecilia Zuppi, Franco Ameglio, Andrea Brancaccio, Francesca Sciandra.   

Abstract

BACKGROUND: Dystroglycan (DG) is an extracellular matrix receptor that serves as an adhesion molecule and is essential for the stability of the plasma membrane. DG is highly expressed within the epithelial cell layer where it supports morphogenesis, adhesion and wound repair. Mechanically ventilated newborns often develop bronchopulmonary dysplasia (BPD), characterized by a progressive impairment of wound repair capacity in their lung.
METHODS: To verify if the susceptibility to BPD might be linked to genetic abnormalities in the DG gene (DAG1), we searched for possible mutations in 33 premature newborns with gestational age<34 weeks with risk of developing BPD. DAG1 genotype was determined in 11 premature newborns with BPD as compared to 22 premature infants without lung complications.
RESULTS: Eight polymorphisms were found, four of them being new DAG1 single nucleotide polymorphisms (SNPs). Only one significant association was found with BPD positive infants: the N494H homozygous genotype (p=0.033). The same polymorphism was found significantly associated with BPD when allelic frequencies were considered (p=0.0015).
CONCLUSIONS: Our data enrich the list of DAG1 SNPs and could be useful to trigger further genetic studies about the involvement of DG in human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196572     DOI: 10.1016/j.cca.2006.11.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants.

Authors:  Joanna Floros; Douglas Londono; Derek Gordon; Patricia Silveyra; Susan L Diangelo; Rose M Viscardi; George S Worthen; Jeffrey Shenberger; Guirong Wang; Zhenwu Lin; Neal J Thomas
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

Review 2.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

3.  The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.

Authors:  Deniz Anuk Ince; Fatma Belgin Atac; Servet Ozkiraz; Ugur Dilmen; Hande Gulcan; Aylin Tarcan; Namik Ozbek
Journal:  Genet Test Mol Biomarkers       Date:  2010-09-06

Review 4.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

Review 5.  The genetic predisposition to bronchopulmonary dysplasia.

Authors:  Kun-Hsing Yu; Jingjing Li; Michael Snyder; Gary M Shaw; Hugh M O'Brodovich
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

Review 6.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

7.  The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of α-dystroglycan.

Authors:  Sonia Covaceuszach; Manuela Bozzi; Maria Giulia Bigotti; Francesca Sciandra; Petr V Konarev; Andrea Brancaccio; Alberto Cassetta
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.